<p>A) Immunization of females with TRAMP-GMCSF cells produces augmented CD4 responses against DBY and CD8 responses against SPAS-1. Male and female B6 mice were injected intradermally with 1×10<sup>6</sup> irradiated TRAMP-GMCSF at days −9, −6, and −3 prior to sacrifice. CD4+ and CD8+ splenocytes were purified with magnetic beads and restimulated with CD11c+ female splenic DCs pulsed with the indicated peptide, or alternatively were stimulated with anti-CD3ε/anti-CD28 beads, or with phorbol myristate acetate (PMA) and ionomycin. Supernatant concentrations of IFN-γ and other cytokines were assayed by BD cytometric bead array. Results of a single experiment. B) DNA vaccination with SPAS-1 produces immune responses in male mice adoptively tran...
<p><b>A</b>, Immunization schedule to evaluate the immunogenicity of the SIVgag-LC3b fusion antigen....
<p>(<b>A</b>) Description of the different vectors employed in the DNA/MVA immunization schemes appl...
<p>C57BL/6 mice were immunized with an empty vector, cytokines only, or D/P vaccine (V1 dose: TcG2- ...
<p>The tumor-bearing mice were treated with AC PSs, HER-2/neu DNA vaccine, or the combination as ind...
<p>A) Adult male mice were myeloablated via irradiation and transplanted with female T-cell depleted...
<p>Mice were immunized as described in <a href="http://www.plosone.org/article/info:doi/10.1371/jour...
<p>Mice were primed two times by immunization with the pCGWHc plasmid. Four weeks later boosting imm...
<p>A. CD40-B cell vaccination generates CD8<sup>+</sup> Te cells but not Tm cells. 10<sup>6</sup> fe...
DNA-based vaccines represent a novel method of immunization that has been demonstrated to induce i...
<p>(A) Schematic diagram depicting the adoptive transfer and vaccination schedule. After C57BL/6 mic...
<p><b>(A)</b> Mice (N = 5/group) were vaccinated 3 times (week 0, 3 and 6) with 20 µg of a plasmid e...
<p>(<b>A</b>) Vaccination schedule used. (<b>B</b>) Cumulative IFN-γ ELISPOT CD8<sup>+</sup> and CD4...
<p>Mice were immunized twice via the IM route with DNA vaccine encoding Ag85B and/or flagellin as sh...
<p>C57BL/6 mice were vaccinated with 25 μg of the indicated plasmids on days 0 and 21. One day follo...
<p>Δ <b>boosts.</b> (A) Schematic schedules of DNA prime/m8Δ-Env boost vaccination protocol. Mice we...
<p><b>A</b>, Immunization schedule to evaluate the immunogenicity of the SIVgag-LC3b fusion antigen....
<p>(<b>A</b>) Description of the different vectors employed in the DNA/MVA immunization schemes appl...
<p>C57BL/6 mice were immunized with an empty vector, cytokines only, or D/P vaccine (V1 dose: TcG2- ...
<p>The tumor-bearing mice were treated with AC PSs, HER-2/neu DNA vaccine, or the combination as ind...
<p>A) Adult male mice were myeloablated via irradiation and transplanted with female T-cell depleted...
<p>Mice were immunized as described in <a href="http://www.plosone.org/article/info:doi/10.1371/jour...
<p>Mice were primed two times by immunization with the pCGWHc plasmid. Four weeks later boosting imm...
<p>A. CD40-B cell vaccination generates CD8<sup>+</sup> Te cells but not Tm cells. 10<sup>6</sup> fe...
DNA-based vaccines represent a novel method of immunization that has been demonstrated to induce i...
<p>(A) Schematic diagram depicting the adoptive transfer and vaccination schedule. After C57BL/6 mic...
<p><b>(A)</b> Mice (N = 5/group) were vaccinated 3 times (week 0, 3 and 6) with 20 µg of a plasmid e...
<p>(<b>A</b>) Vaccination schedule used. (<b>B</b>) Cumulative IFN-γ ELISPOT CD8<sup>+</sup> and CD4...
<p>Mice were immunized twice via the IM route with DNA vaccine encoding Ag85B and/or flagellin as sh...
<p>C57BL/6 mice were vaccinated with 25 μg of the indicated plasmids on days 0 and 21. One day follo...
<p>Δ <b>boosts.</b> (A) Schematic schedules of DNA prime/m8Δ-Env boost vaccination protocol. Mice we...
<p><b>A</b>, Immunization schedule to evaluate the immunogenicity of the SIVgag-LC3b fusion antigen....
<p>(<b>A</b>) Description of the different vectors employed in the DNA/MVA immunization schemes appl...
<p>C57BL/6 mice were immunized with an empty vector, cytokines only, or D/P vaccine (V1 dose: TcG2- ...